Cargando…
Valproate therapy exacerbating intermediate phenotype of methylmalonic aciduria
A, 11-year-old male, with delayed milestones after the age of 6 months with recurrent myoclonus and generalized tonic-clonic seizures had clinical worsening after institution of valproate, was detected to have elevated serum lactate level and marked methyl malonic aciduria. Patient had remarkable im...
Autores principales: | Murgai, Aditya, Deshmukh, Aviraj, Puri, Vinod, Chaudhry, Neera, Kapoor, Seema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489058/ https://www.ncbi.nlm.nih.gov/pubmed/26167218 http://dx.doi.org/10.4103/1817-1745.159203 |
Ejemplares similares
-
Mouse Models for Methylmalonic Aciduria
por: Peters, Heidi L., et al.
Publicado: (2012) -
Renal Involvement in Methylmalonic Aciduria
por: Alkhunaizi, Ahmed M., et al.
Publicado: (2017) -
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes unveiled by valproate
por: Chaudhry, Neera, et al.
Publicado: (2013) -
Monitoring Methylmalonic Aciduria by NMR Urinomics
por: Nicolescu, Alina, et al.
Publicado: (2020) -
Acrodermatitis dysmetabolica as a sign of methylmalonic aciduria decompensation
por: Rosa, Joana, et al.
Publicado: (2018)